Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0017337,
umls-concept:C0024264,
umls-concept:C0061024,
umls-concept:C0086418,
umls-concept:C0205100,
umls-concept:C0205314,
umls-concept:C0439097,
umls-concept:C0679622,
umls-concept:C1171362,
umls-concept:C1264633,
umls-concept:C1515670,
umls-concept:C1547348,
umls-concept:C1552644,
umls-concept:C1705241,
umls-concept:C1823153,
umls-concept:C2349976
|
pubmed:issue |
12
|
pubmed:dateCreated |
1989-3-14
|
pubmed:abstractText |
We have characterized a functional T cell receptor (TcR) delta transcript in a Ti gamma A+ human cloned cell line derived from peripheral blood. This cDNA includes a novel V gene (V-AB12), whose expression was initially studied in a series of TcR gamma/delta+ clones. Nine Ti gamma A+ clones derived independently from distinct donors have been tested: each of them was found to possess a unique V-AB12/J-IDP2 5.5-kb Eco RI rearrangement, which was constantly transcribed. Surface expression of the protein encoded by this unique rearranged gene was demonstrated by immunoprecipitations performed on three Ti gamma A+ polyclonal cell lines using a specific rabbit heteroantiserum. Further analysis strongly suggested that a monoclonal antibody (mAb), designated anti-BB3, detects a V-AB12-encoded antigenic determinant on the cell surface. Double-color immunofluorescence analysis of peripheral blood lymphocytes from ten donors indicated that most BB3+ cells are recognized by anti-Ti gamma A mAb. In previous studies, we have shown that a majority of TcR gamma/delta+ peripheral T cells expresses a gamma chain including V9 (Ti gamma A) and most frequently JP-encoded peptides. Given the present results on the delta chain, it can be concluded that, in many individuals, a predominant fraction (V gamma 9+/V-AB12+) of circulating CD3+ TcR alpha/beta- T lymphocytes expresses a receptor with little, if any, combinatorial diversity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0014-2980
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2021-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2975601-Amino Acid Sequence,
pubmed-meshheading:2975601-Base Sequence,
pubmed-meshheading:2975601-Cell Differentiation,
pubmed-meshheading:2975601-Cloning, Molecular,
pubmed-meshheading:2975601-DNA,
pubmed-meshheading:2975601-Gene Expression Regulation,
pubmed-meshheading:2975601-Gene Rearrangement, T-Lymphocyte,
pubmed-meshheading:2975601-Humans,
pubmed-meshheading:2975601-Molecular Sequence Data,
pubmed-meshheading:2975601-Precipitin Tests,
pubmed-meshheading:2975601-RNA, Messenger,
pubmed-meshheading:2975601-Receptors, Antigen, T-Cell,
pubmed-meshheading:2975601-Receptors, Antigen, T-Cell, gamma-delta,
pubmed-meshheading:2975601-T-Lymphocytes,
pubmed-meshheading:2975601-Tumor Cells, Cultured
|
pubmed:year |
1988
|
pubmed:articleTitle |
A novel human V delta gene expressed predominantly in the Ti gamma A fraction of gamma/delta+ peripheral lymphocytes.
|
pubmed:affiliation |
Laboratoire d'Immunologie Cellulaire, Institut Gustave-Roussy, Villejuif, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|